HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD
Overall HIMS gets a fundamental rating of 6 out of 10. We evaluated HIMS against 103 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS is valued quite expensively, but it does show have an excellent growth rating. With these ratings, HIMS could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
HIMS had a positive operating cash flow in the past year.
HIMS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 18.44%, HIMS belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 29.93%, HIMS belongs to the top of the industry, outperforming 95.15% of the companies in the same industry.
With an excellent Return On Invested Capital value of 14.93%, HIMS belongs to the best of the industry, outperforming 92.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROIC | 14.93% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 9.21%. This is amongst the best in the industry. HIMS outperforms 93.20% of its industry peers.
The Operating Margin of HIMS (6.48%) is better than 67.96% of its industry peers.
HIMS has a better Gross Margin (77.04%) than 91.26% of its industry peers.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HIMS is still creating some value.
Compared to 1 year ago, HIMS has more shares outstanding
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 26.88 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS has a Altman-Z score of 26.88. This is amongst the best in the industry. HIMS outperforms 98.06% of its industry peers.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 26.88 |
ROIC/WACC1.68
WACC8.87%
2.3 Liquidity
A Current Ratio of 1.59 indicates that HIMS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.59, HIMS is in line with its industry, outperforming 55.34% of the companies in the same industry.
A Quick Ratio of 1.32 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS's Quick ratio of 1.32 is in line compared to the rest of the industry. HIMS outperforms 48.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 7000.00% over the past year.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 85.99%.
Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 75.77% on average per year.
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
3.2 Future
HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.75% yearly.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.96% yearly.
EPS Next Y26.18%
EPS Next 2Y33.82%
EPS Next 3Y33.56%
EPS Next 5Y41.75%
Revenue Next Year60%
Revenue Next 2Y38.65%
Revenue Next 3Y32.28%
Revenue Next 5Y24.96%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 90.65, which means the current valuation is very expensive for HIMS.
HIMS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.82, HIMS is valued quite expensively.
HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 64.69.
HIMS's Price/Forward Earnings is on the same level as the industry average.
HIMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.21.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.65 | ||
| Fwd PE | 64.69 |
4.2 Price Multiples
63.11% of the companies in the same industry are cheaper than HIMS, based on the Enterprise Value to EBITDA ratio.
HIMS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.2 | ||
| EV/EBITDA | 98.81 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of HIMS may justify a higher PE ratio.
HIMS's earnings are expected to grow with 33.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.46
PEG (5Y)1.5
EPS Next 2Y33.82%
EPS Next 3Y33.56%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
62.55
-3.63 (-5.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners73.96%
Inst Owner Change-0.68%
Ins Owners10.67%
Ins Owner Change9.75%
Market Cap14.00B
Analysts70
Price Target49.22 (-21.31%)
Short Float %34.25%
Short Ratio1.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.39%
Min EPS beat(2)4.62%
Max EPS beat(2)62.17%
EPS beat(4)4
Avg EPS beat(4)192.83%
Min EPS beat(4)4.62%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)156.65%
EPS beat(12)11
Avg EPS beat(12)110.67%
EPS beat(16)12
Avg EPS beat(16)78.36%
Revenue beat(2)2
Avg Revenue beat(2)3.52%
Min Revenue beat(2)0.3%
Max Revenue beat(2)6.75%
Revenue beat(4)4
Avg Revenue beat(4)3.3%
Min Revenue beat(4)0.3%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.56%
Revenue beat(12)10
Avg Revenue beat(12)2.89%
Revenue beat(16)14
Avg Revenue beat(16)3.76%
PT rev (1m)-1.71%
PT rev (3m)8.45%
EPS NQ rev (1m)1.49%
EPS NQ rev (3m)3.25%
EPS NY rev (1m)-0.46%
EPS NY rev (3m)8.82%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)-2.63%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.65 | ||
| Fwd PE | 64.69 | ||
| P/S | 7.85 | ||
| P/FCF | 59.2 | ||
| P/OCF | 41.88 | ||
| P/B | 25.49 | ||
| P/tB | 36.08 | ||
| EV/EBITDA | 98.81 |
EPS(TTM)0.69
EY1.1%
EPS(NY)0.97
Fwd EY1.55%
FCF(TTM)1.06
FCFY1.69%
OCF(TTM)1.49
OCFY2.39%
SpS7.97
BVpS2.45
TBVpS1.73
PEG (NY)3.46
PEG (5Y)1.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.44% | ||
| ROE | 29.93% | ||
| ROCE | 18.9% | ||
| ROIC | 14.93% | ||
| ROICexc | 31.63% | ||
| ROICexgc | 71.61% | ||
| OM | 6.48% | ||
| PM (TTM) | 9.21% | ||
| GM | 77.04% | ||
| FCFM | 13.25% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score6
Asset Turnover2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 437.46% | ||
| Cap/Sales | 5.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 242.39% | ||
| Profit Quality | 143.86% | ||
| Current Ratio | 1.59 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z | 26.88 |
F-Score6
WACC8.87%
ROIC/WACC1.68
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7000%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%300%
EPS Next Y26.18%
EPS Next 2Y33.82%
EPS Next 3Y33.56%
EPS Next 5Y41.75%
Revenue 1Y (TTM)85.99%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%110.67%
Revenue Next Year60%
Revenue Next 2Y38.65%
Revenue Next 3Y32.28%
Revenue Next 5Y24.96%
EBIT growth 1Y2214.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year366.35%
EBIT Next 3Y97.77%
EBIT Next 5Y66.66%
FCF growth 1Y3973.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14096.9%
OCF growth 3YN/A
OCF growth 5YN/A